Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
408.00
+2.00 (0.49%)
Apr 28, 2026, 1:30 PM CST
-28.43%
Market Cap 51.81B
Revenue (ttm) 19.01B
Net Income (ttm) 2.98B
Shares Out 126.99M
EPS (ttm) 15.81
PE Ratio 17.56
Forward PE 17.95
Dividend 10.00 (2.46%)
Ex-Dividend Date Jun 20, 2025
Volume 419,534
Average Volume 860,642
Open 408.00
Previous Close 406.00
Day's Range 406.00 - 412.00
52-Week Range 400.00 - 795.00
Beta 0.79
RSI 38.36
Earnings Date May 12, 2026

About Bora Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti... [Read more]

Sector Healthcare
Founded 2007
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6472
Full Company Profile

Financial Performance

In 2025, Bora Pharmaceuticals's revenue was 19.01 billion, an increase of 9.11% compared to the previous year's 17.43 billion. Earnings were 2.98 billion, a decrease of -22.61%.

Financial Statements

News

There is no news available yet.